Overview TBI Dose De-escalation for Fanconi Anemia Status: Completed Trial end date: 2020-10-09 Target enrollment: Participant gender: Summary This is a single arm, total body irradiation (TBI) trial. All patients will be prescribed TBI 300 cGy with the goal of evaluating secondary endpoints. Phase: Phase 2/Phase 3 Details Lead Sponsor: Masonic Cancer Center, University of MinnesotaTreatments: CyclophosphamideEverolimusFludarabineFludarabine phosphateMycophenolate mofetilMycophenolic AcidSirolimus